|
|
Article: MPI Research Announces Strategic Collaboration with Kineta.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MPI Research, a preclinical Contract Research Organization (CRO), announced that it will be collaborating with Kineta, Inc, a Seattle-based privately held biotechnology company specializing in clinical advancement of drugs that modulate and enhance the human immune system. MPI Research will assist Kineta with advancing their promising autoimmune drug development program. This collaboration will enable phase one human trials to begin in 2010 (see also MPI Research).
Dr. Tina Rogers, PhD, MBA, DABT, Director of Research and Executive Vice President at MPI Research, states, "We have a team of great scientists highly knowledgeable about autoimmune diseases and we are ...